English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Crystals of urokinase type plasminogen activator complexes reveal the binding mode of peptidomimetic inhibitors

Zeslawska, E., Jacob, U., Schweinitz, A., Coombs, G., Bode, W., & Madison, E. (2003). Crystals of urokinase type plasminogen activator complexes reveal the binding mode of peptidomimetic inhibitors. Journal of Molecular Biology, 328(1), 109-118.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : J. Mol. Biol.

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Zeslawska, E., Author
Jacob, U.1, Author           
Schweinitz, A., Author
Coombs, G., Author
Bode, W.1, 2, 3, Author           
Madison, E., Author
Affiliations:
1Huber, Robert / Structure Research, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565155              
2Fässler, Reinhard / Molecular Medicine, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565147              
3Conti, Elena / Structural Cell Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565144              

Content

show
hide
Free keywords: urokinase; proteinase; inhibitor; structure-activity relation; cancer
 Abstract: Urokinase type plasminogen activator (uPA), a trypsin-like serine proteinase, plays an important role in normal tissue re- modelling, cell adhesion, and cell motility. In addition, studies utilizing normal animals and potent, selective uPA inhibitors or genetically modified mice that lack functional uPA genes have demonstrated that uPA can significantly enhance tumor initiation, growth, progression and metastasis, strongly suggesting that this enzyme may be a promising anti-cancer target. We have investigated the structure-activity relationship (SAR) of peptidomimetic inhibitors of uPA and solved high resolution X-ray structures of key, lead small molecule inhibitors (e.g. phenethylsulfonamidino(P4)D- Beryl(P3)-L-alanyl(P2)-L-argininal(PI) and derivatives thereof) in complex with the uPA proteinase domain. These potent inhibitors are highly selective for uPA. The non-natural D- Beryl residue present at the P3 position in these inhibitors. contributes substantially to both potency and selectivity because, due to its D-configuration, its side-chain binds in the S4 pocket to interact with the uPA unique residues Leu97b and His99. Additional potency and selectivity can be achieved by optimizing the inhibitor P4 residue to bind a pocket, known as S1sub or S1beta, that is adjacent to the primary specificity pocket of uPA. (C) 2003 Elsevier Science Ltd. All rights reserved.

Details

show
hide
Language(s): eng - English
 Dates: 2003-04-18
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 35297
ISI: 000182277200009
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Molecular Biology
  Alternative Title : J. Mol. Biol.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 328 (1) Sequence Number: - Start / End Page: 109 - 118 Identifier: ISSN: 0022-2836